MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

NCT01121237 · clinicaltrials.gov ↗

COMPLETED

Status

2086

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
End-stage Renal Disease
Anaemia

Interventions

DRUG: Recombinant human erythropoietin alfa (biosimilar)

Sponsor

Sandoz

Collaborators

[object Object]